ARCHIVES

NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial.

This article is from The Cancer Letter archive.

Vol. 33 No. 15 | April 20, 2007

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

December 29, 2006

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

McKesson To Purchase US Oncology

November 5, 2010

NCI-Funded Modelers Accurately Predicted Outcome Of Lung Cancer Screening Trial

November 26, 2010

President’s Budget Asks $1.646 Billion for NCI In FY 1990, Including AIDS, 3% Increase Over ‘89

January 13, 1989

NSABP Investigator Recounts Loyalty To Fisher, “Betrayal”

June 3, 1994